Be Prepared.
Be Confident.
With Icatibant Injection for Hereditary Angioedema (HAE)
Be prepared to treat Hereditary Angioedema (HAE) attacks. Be confident by carrying Icatibant Injection with you at all times. Generic Icatibant Injection is FDA-approved, providing a fully substitutable, chemically equivalent,* and affordable option when treating acute attacks of HAE.
Icatibant Injection is a medicine used to treat acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older. It is not known if Icatibant Injection is safe or effective for children under 18 years of age.
*Fresenius Kabi’s Icatibant Injection is fully substitutable and chemically equivalent to Firazyr®.
On-Demand Treatment
for HAE Attacks
Convenient, on-demand treatment gives you the confidence you need to live freely, knowing you have a medicine you can use at the first signs of HAE symptoms.
Sensible and Effective
Treatment Option
Icatibant Injection, manufactured by Fresenius Kabi, is less expensive, easy to use, and made with the same quality ingredients as the brand-name product.
A Trustworthy,
Reliable Source
Fresenius Kabi is a leading provider of generic medications with a 100-year history of delivering innovative therapies that are safe, efficient, and affordable.
